Childhood urticaria and angioedema: pathogenesis diagnosis and therapy

Yıl 2012, Cilt: 47 Sayı: 4, 235 - 239, 01.12.2012

İşıl Barlan Safa Barış

https://doi.org/10.4274/tpa.1679

Öz

Urticarial disease is characterized by transient erythematous swelling and pruritic lesions Classification of the disease as acute and chronic urticeria provide a comprehensive approach to detect the etiological factors and estimate the prognosis In this paper clinical classification of urticeria pathogenesis related factors with disease and therapy options were reviewed Turk Arch Ped 2012; 47: 235 9

Anahtar Kelimeler

-

Çocukluk çağında ürtiker ve anjiyoödem: patojenez tanı ve tedavi

Öz

Ürtiker deride geçici olarak ortaya çıkan kızarıklık kabarma ve kaşıntı ile belirgin bir hastalıktır Akut ve kronik olarak klinik sınıflamanın yapılması etiolojik etkenlerin araştırılması ve klinik seyrin belirlenmesi açısından önemlidir Bu derlemede ürtiker ve anjiyoödemin klinik sınıflaması patojenez hastalığa neden olabilecek etmenler ve tedavi hakkında bilgi verilmiştir.

Anahtar Kelimeler

Anjiyoödem, çocuk, ürtiker

Kaynakça

• Kaplan AP. Urticaria and angioedema. In: Adkinson NF, Yunginer JW, Busse WW (eds). Allergy principles and practice. Vol.2, Ch.85. 6th ed. St. Louis, Missouri: Mosby-Year Book Inc, 2003: 1537-59.
• Toubi E, Kessel A, Avshovich N, et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy 2004; 59: 869-73.
• Vonakis BM, Saini SS. New concepts in chronic urticaria. Curr Opin Immunol 2008; 20: 709-16.
• Kaplan AP. Clinical practice: chronic urticeria and angioedema. N Engl J Med 2002; 346: 175-9.
• Kaplan AP, Greaves M. Pathogenesis of chronic urticeria. Clin Exp Allergy 2009; 39: 777-87.
• Grattan CE, Dawn G, Gibbs S, Francis DM. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity. Clin Exp Allergy 2003; 33: 337-41.
• Hide M, Francis D, Grattan C, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328: 1599-604.
• Ying S, Kikuchi Y, Meng Q, Kay AB, Kaplan AP. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 2002; 109: 694-700.
• Macglashan D, Miura K. Loss of syk kinase during IgE-mediated stimulation of human basophils. J Allergy Clin Immunol 2004; 114: 1317-24.
• Leung WH, Bolland S. The inositol 5’-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production. J Immunol 2007; 179: 95-102.
• Bailey E, Shaker M. An update on childhood urticeria and angioedema. Curr Opin Pediatr 2008; 20: 425-30.
• Brunetti L, Francavilla, Miniello V. High prevalence of autoimmune urticaria in children with chronic urticaria. J Allergy Clin Immunol 2004; 114: 922-7.
• Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64(10): 1417-26.
• Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2) LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64(10): 1427-43.
• Düzova A, Adalıoğlu G. Ürtiker ve anjioödem. Katkı Pediatri Dergisi (Astma ve Alerjik Hastalıklar) 1997; 18: 789-99.
• Volonakis M, Katsaru-Katsari A, Stratigos J. Aetiologic factors in childhood chronic urticaria. Ann Allergy 1992; 69: 61-5.
• Grattan CEH, Sabroe RA, Greaves MW. Chronic urticeria. J Am Acad Dermatol 2003; 46: 645-57.
• Burova G, Mallet A, Greaves M. Is Helicobacter pylori a cause of chronic urticeria. Br J Dermatol 1998; 139(suppl 1): 42.
• Leznoff A, Josse R, Denburg J, Dolovich J. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 1983; 119: 636-40.
• Turktas I, Gokcora N, Demirsoy S, Cakir N, Onal E. The association of chronic urticaria and angioedema with autoimmune thyroiditis. Int J Dermatol 1997; 36: 187-90.
• Lindelöf B, Sigurgeirsson B, Wahlgren CF, Eklund G. Chronic urticaria and cancer: an epidemiological study of 1155 patients. Br J Dermatol 1990; 123: 453-6.
• Dibbern DA, Dreskin SC. Urticaria and angioedema: an overview. Immunol Allergy Clin N Am 2004; 24: 141-62.
• Thomas P, Perkin MR, Rayner N. The investigation of chronic urticaria in childhood: which investigations are being performed and which are recommended? Clin Exp Allergy 2008; 38(6): 1061-2.
• Greaves MW. Chronic urticaria. N Engl J Med 1995; 332(26): 1767-72.
• Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid- Grendelmeier P, Grattan CE. EAACI/GA2LEN position paper: the autologous serum skin test in urticaria: literature review and consensus panel recommendations. Allergy 2009; 64(9): 1256-68.
• Dice JP. Physical urticaria. Immunol Allergy Clin N Am 2004: 24; 225-46.
• Goldsobel AB, Rohr AS, Siegel SC, et al. Efficacy of doxepin in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1986; 78: 867-73.
• Greene SL, Reed CE, Schroeter AL. Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol 1985; 12: 669-75.
• Kozel MM, Sabroe RA. Chronic urticaria: aetiology, management and current and future treatment options. Drugs 2004; 64: 2515-36.
• Engin B, Ozdemir M. Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol 2008; 22(4): 481-6.
• Magerl M, Philipp S, Manasterski M, Friedrich M, Maurer M. Successful treatment of delayed pressure urticaria with anti-TNF-alpha. J Allergy Clin Immunol 2007; 119(3): 752-4.
• O’Donnell BF, Barr RM, Black AK, et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998; 138: 101-6.
• Spector SL, Tan RA. Effect of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol 2007; 99: 190-3.